Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Pexidartinib often causes liver issues and fatigue, especially in women.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

A vitamin D3 compound can reduce skin cell growth.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Rebamipide may help regrow hair by activating hair follicle stem cells.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

The peptide GPIGS helps hair cells grow and speeds up hair regrowth in mice.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Drugs like PDEI may help hair disorders like AGA.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Upadacitinib improved multiple immune-related conditions in one patient.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.